Hantz Financial Services Inc. Raises Stock Holdings in Tenet Healthcare Corporation $THC

Hantz Financial Services Inc. grew its stake in Tenet Healthcare Corporation (NYSE:THC) by 44.0% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,106 shares of the company’s stock after acquiring an additional 644 shares during the quarter. Hantz Financial Services Inc.’s holdings in Tenet Healthcare were worth $371,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Price T Rowe Associates Inc. MD lifted its position in shares of Tenet Healthcare by 6.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 7,596,544 shares of the company’s stock valued at $1,021,736,000 after acquiring an additional 463,552 shares in the last quarter. Ameriprise Financial Inc. increased its stake in Tenet Healthcare by 348.4% in the first quarter. Ameriprise Financial Inc. now owns 1,962,314 shares of the company’s stock valued at $263,905,000 after purchasing an additional 1,524,642 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Tenet Healthcare by 12.2% in the first quarter. Dimensional Fund Advisors LP now owns 1,675,199 shares of the company’s stock valued at $225,297,000 after purchasing an additional 181,667 shares during the last quarter. Nuveen LLC acquired a new position in Tenet Healthcare in the first quarter valued at $218,549,000. Finally, Boston Partners increased its stake in Tenet Healthcare by 692.9% in the first quarter. Boston Partners now owns 1,162,642 shares of the company’s stock valued at $156,318,000 after purchasing an additional 1,016,010 shares during the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently commented on THC. Weiss Ratings reiterated a “hold (c+)” rating on shares of Tenet Healthcare in a research note on Wednesday, October 8th. Guggenheim upped their target price on Tenet Healthcare from $221.00 to $238.00 and gave the company a “buy” rating in a research note on Wednesday. Wall Street Zen upgraded Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Saturday, July 26th. Raymond James Financial set a $245.00 price target on Tenet Healthcare in a research note on Wednesday. Finally, JPMorgan Chase & Co. upped their price target on Tenet Healthcare from $190.00 to $200.00 and gave the stock an “overweight” rating in a research note on Monday, August 4th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $225.31.

Insider Buying and Selling

In other news, Director Richard W. Fisher sold 2,500 shares of the company’s stock in a transaction dated Wednesday, October 29th. The stock was sold at an average price of $208.43, for a total value of $521,075.00. Following the completion of the sale, the director owned 8,792 shares of the company’s stock, valued at $1,832,516.56. This represents a 22.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Christopher S. Lynch sold 3,952 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $176.39, for a total value of $697,093.28. Following the completion of the sale, the director directly owned 12,358 shares of the company’s stock, valued at $2,179,827.62. The trade was a 24.23% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 93,222 shares of company stock worth $17,682,090 over the last three months. 0.81% of the stock is currently owned by corporate insiders.

Tenet Healthcare Stock Performance

Shares of NYSE:THC opened at $206.53 on Monday. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $217.43. The business has a 50-day moving average of $195.84 and a two-hundred day moving average of $173.45. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.63. The firm has a market capitalization of $18.25 billion, a PE ratio of 14.16, a P/E/G ratio of 0.89 and a beta of 1.52.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, topping the consensus estimate of $3.33 by $0.37. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The company had revenue of $5.29 billion during the quarter, compared to the consensus estimate of $5.26 billion. During the same quarter in the prior year, the business earned $2.93 earnings per share. The company’s revenue was up 3.2% compared to the same quarter last year. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. As a group, research analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.